GCM
ABBV icon

Gladius Capital Management’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$218K Sell
1,173
-4,294
-79% -$797K 0.08% 25
2025
Q1
$1.15M Sell
5,467
-3,590
-40% -$752K 0.3% 21
2024
Q4
$1.61M Buy
9,057
+2,667
+42% +$474K 0.17% 24
2024
Q3
$1.26M Buy
6,390
+2,149
+51% +$424K 0.15% 29
2024
Q2
$727K Buy
4,241
+1,798
+74% +$308K 0.09% 44
2024
Q1
$445K Buy
+2,443
New +$445K 0.15% 53
2023
Q4
Sell
-8,844
Closed -$1.32M 228
2023
Q3
$1.32M Buy
8,844
+3,455
+64% +$515K 0.06% 32
2023
Q2
$726K Buy
5,389
+3,632
+207% +$489K 0.04% 24
2023
Q1
$280K Sell
1,757
-953
-35% -$152K 0.02% 60
2022
Q4
$438K Sell
2,710
-6,357
-70% -$1.03M 0.03% 56
2022
Q3
$1.22M Buy
9,067
+7,374
+436% +$990K 0.05% 44
2022
Q2
$260K Sell
1,693
-5,325
-76% -$818K 0.01% 90
2022
Q1
$1.14M Buy
7,018
+5,280
+304% +$856K 0.08% 23
2021
Q4
$236K Buy
1,738
+1,001
+136% +$136K 0.02% 84
2021
Q3
$80K Buy
737
+302
+69% +$32.8K 0.01% 19
2021
Q2
$49K Buy
+435
New +$49K ﹤0.01% 23
2021
Q1
Hold
0
38
2020
Q4
Sell
-3,104
Closed -$272K 40
2020
Q3
$272K Buy
+3,104
New +$272K 0.03% 43
2020
Q1
Sell
-426
Closed -$38K 44
2019
Q4
$38K Sell
426
-5,485
-93% -$489K ﹤0.01% 35
2019
Q3
$448K Sell
5,911
-349
-6% -$26.5K 0.02% 50
2019
Q2
$460K Sell
6,260
-19,882
-76% -$1.46M 0.03% 39
2019
Q1
$2.11M Sell
26,142
-1,294
-5% -$104K 0.12% 35
2018
Q4
$2.53M Buy
27,436
+24,291
+772% +$2.24M 0.12% 41
2018
Q3
$297K Sell
3,145
-4,567
-59% -$431K 0.03% 29
2018
Q2
$715 Buy
+7,712
New +$715 0.07% 28